DE69431131T2 - Thioxanthenone als Antitumor Mittel - Google Patents

Thioxanthenone als Antitumor Mittel

Info

Publication number
DE69431131T2
DE69431131T2 DE69431131T DE69431131T DE69431131T2 DE 69431131 T2 DE69431131 T2 DE 69431131T2 DE 69431131 T DE69431131 T DE 69431131T DE 69431131 T DE69431131 T DE 69431131T DE 69431131 T2 DE69431131 T2 DE 69431131T2
Authority
DE
Germany
Prior art keywords
ch2n
alkyl
hydrogen
hydroxy
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69431131T
Other languages
English (en)
Other versions
DE69431131D1 (de
Inventor
Mark Philip Wentland
Robert Bruno Perni
Joseph William Guiles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Application granted granted Critical
Publication of DE69431131D1 publication Critical patent/DE69431131D1/de
Publication of DE69431131T2 publication Critical patent/DE69431131T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655363Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
    • C07F9/655372Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12Thioxanthenes
    • C07D335/14Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D335/16Oxygen atoms, e.g. thioxanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69431131T 1993-04-08 1994-03-31 Thioxanthenone als Antitumor Mittel Expired - Fee Related DE69431131T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/044,843 US5346917A (en) 1991-06-10 1993-04-08 Thioxanthenone antitumor agents

Publications (2)

Publication Number Publication Date
DE69431131D1 DE69431131D1 (de) 2002-09-05
DE69431131T2 true DE69431131T2 (de) 2003-03-27

Family

ID=21934632

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69431131T Expired - Fee Related DE69431131T2 (de) 1993-04-08 1994-03-31 Thioxanthenone als Antitumor Mittel
DE69418929T Expired - Fee Related DE69418929T2 (de) 1993-04-08 1994-03-31 Thioxanthenone als Antitumormittel
DE69434216T Expired - Fee Related DE69434216T2 (de) 1993-04-08 1994-03-31 Thioxanthenon Antitumormittel

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE69418929T Expired - Fee Related DE69418929T2 (de) 1993-04-08 1994-03-31 Thioxanthenone als Antitumormittel
DE69434216T Expired - Fee Related DE69434216T2 (de) 1993-04-08 1994-03-31 Thioxanthenon Antitumormittel

Country Status (24)

Country Link
US (2) US5346917A (de)
EP (3) EP1197491B1 (de)
JP (1) JPH06340655A (de)
KR (1) KR100344136B1 (de)
AT (3) ATE221524T1 (de)
AU (1) AU679717B2 (de)
CA (1) CA2120782C (de)
CZ (1) CZ289473B6 (de)
DE (3) DE69431131T2 (de)
DK (3) DK0882723T3 (de)
ES (3) ES2180100T3 (de)
FI (2) FI941638A (de)
GR (1) GR3030949T3 (de)
HU (1) HUT67899A (de)
IL (1) IL109241A (de)
MY (1) MY131770A (de)
NO (1) NO306947B1 (de)
NZ (1) NZ260255A (de)
PT (2) PT882723E (de)
RU (1) RU2138495C1 (de)
SG (1) SG52765A1 (de)
SK (1) SK283799B6 (de)
TW (1) TW242623B (de)
UA (1) UA41281C2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665760A (en) * 1995-09-18 1997-09-09 Sanofi Winthrop, Inc. Lyophilized thioxanthenone antitumor agents
US7126011B2 (en) * 2000-11-15 2006-10-24 Prom Limited Process for the preparation of thioxanthones
GB0115893D0 (en) * 2001-06-28 2001-08-22 Sanofi Synthelabo Formulations
US6747039B2 (en) * 2002-03-12 2004-06-08 Albany Molecular Research, Inc. Aza-benzothiopyranoindazoles with antitumor activity
US20030212061A1 (en) * 2002-03-12 2003-11-13 Haydar Simon N. Aza-thioxanthenones with antitumor activity
BR0316296A (pt) * 2002-11-18 2005-12-13 Arqule Inc Compostos lapacone e seus métodos de uso
US6767919B2 (en) * 2002-12-17 2004-07-27 Walker Cancer Research Institute, Inc. High specificity anticancer agents
US20080114055A1 (en) * 2006-11-10 2008-05-15 Zoltan Laboratories Llc Thioxanthone Compounds to Reverse Weight Loss
US20080207738A1 (en) * 2007-02-28 2008-08-28 Cancure Laboratories, Llc Drug combinations to treat drug resistant tumors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312598A (en) * 1965-06-14 1967-04-04 Sterling Drug Inc Fermentative oxidation of substituted thioxanthenes and xanthenes
US3745172A (en) * 1970-10-05 1973-07-10 Sterling Drug Inc 1-(di-(lower-alkyl)aminoalkylamino)-9-oxothioxanthenes
US4539412A (en) * 1982-07-08 1985-09-03 Rensselaer Polytechnic Institute 7-Hydroxylucanthone, 7-hydroxhycanthone and their analogs
GB8400203D0 (en) * 1984-01-05 1984-02-08 Wellcome Found Tricyclic compounds
US4582851A (en) * 1984-02-06 1986-04-15 Warner-Lambert Company Anti-bacterial 1,4-aminoalkylamino-9H-thioxanthen-9-one derivatives, compositions, and method of use therefor
US5091410A (en) * 1991-06-10 1992-02-25 Sterling Winthrop Inc. Thioxanthenone antitumor agents
AU642596B2 (en) * 1991-06-10 1993-10-21 Sanofi-Synthelabo Thioxanthenone antitumor agents

Also Published As

Publication number Publication date
DK1197491T3 (da) 2005-04-11
UA41281C2 (uk) 2001-09-17
CZ74894A3 (en) 1994-11-16
NO306947B1 (no) 2000-01-17
IL109241A (en) 2001-10-31
EP0619315A1 (de) 1994-10-12
FI941638A (fi) 1994-10-09
DE69418929T2 (de) 2000-01-20
ATE221524T1 (de) 2002-08-15
ATE181068T1 (de) 1999-06-15
MY131770A (en) 2007-08-30
AU5930194A (en) 1994-10-13
EP1197491B1 (de) 2004-12-29
EP1197491A1 (de) 2002-04-17
FI941638A0 (fi) 1994-04-08
IL109241A0 (en) 1994-07-31
NO941288D0 (no) 1994-04-08
SG52765A1 (en) 1998-09-28
EP0619315B1 (de) 1999-06-09
PT1197491E (pt) 2005-04-29
EP0882723A1 (de) 1998-12-09
US5346917A (en) 1994-09-13
DE69431131D1 (de) 2002-09-05
DE69434216T2 (de) 2005-12-08
AU679717B2 (en) 1997-07-10
DK0619315T3 (da) 1999-12-27
HUT67899A (en) 1995-05-29
ATE286043T1 (de) 2005-01-15
HU9400992D0 (en) 1994-06-28
SK283799B6 (sk) 2004-02-03
CZ289473B6 (cs) 2002-01-16
KR100344136B1 (ko) 2003-09-29
NO941288L (no) 1994-10-10
ES2180100T3 (es) 2003-02-01
JPH06340655A (ja) 1994-12-13
PT882723E (pt) 2002-11-29
ES2234935T3 (es) 2005-07-01
GR3030949T3 (en) 1999-11-30
CA2120782A1 (en) 1994-10-09
DE69418929D1 (de) 1999-07-15
NZ260255A (en) 1995-07-26
EP0882723B1 (de) 2002-07-31
US5380749A (en) 1995-01-10
RU2138495C1 (ru) 1999-09-27
DK0882723T3 (da) 2002-11-25
SK39094A3 (en) 1995-07-11
TW242623B (de) 1995-03-11
ES2134314T3 (es) 1999-10-01
FI20041691A (fi) 2004-12-30
DE69434216D1 (de) 2005-02-03
CA2120782C (en) 2005-10-25

Similar Documents

Publication Publication Date Title
ATE221524T1 (de) Thioxanthenone als antitumor mittel
NO922273D0 (no) Tioxantenon-antitumormidler
FI940011A (fi) Mono- ja bis-alkyyliaminoantrasykliinit
BR9405997A (pt) Composições antitumorais e métodos de tratamento

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee